What it is
Mod GRF 1-29 is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH). It is designed to stimulate the pituitary gland to release growth hormone (GH), which plays a role in cellular repair and regeneration.
2 mg · vegan · gluten-free · 30 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
Mod GRF 1-29 is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH). It is designed to stimulate the pituitary gland to release growth hormone (GH), which plays a role in cellular repair and regeneration.
Mod GRF 1-29 binds to GHRH receptors in the anterior pituitary, triggering a pulsatile release of GH. This increased GH can then stimulate the liver to produce IGF-1, a key mediator of GH's anabolic and regenerative effects on tissues.
Adults looking to address premature ageing, low energy, cellular stress. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
C · C · emerging-to-moderate human evidence for healthy ageing and cellular longevity
SacredBod's longer take on Mod GRF 1-29 — context the structured blocks above don't capture.
Mod GRF 1-29 is a peptide supplement used to support healthy ageing and cellular longevity. Modified GRF researched for GH release. It is available in capsule form and dosed for adults in India and internationally. As a peptide-tradition entry in the SacredBod catalog, it is positioned as a single-ingredient option that can be used on its own or layered into a broader protocol. Mod GRF 1-29 works through the mechanisms characteristic of its class — see the mechanism and research sections for detail. It primarily acts on the mitochondria, cells, telomeres, and effects are dose-dependent, typically becoming measurable within 8-12 weeks for longevity markers. Consistency matters more than dose size for this category.
Mod GRF 1-29 carries an evidence grade of C in the SacredBod catalog, reflecting emerging human evidence for healthy ageing and cellular longevity. Modified GRF researched for GH release. Benefits are cumulative rather than immediate, typically becoming noticeable within 8-12 weeks for longevity markers, and individual response varies.
A typical dose is 2 mg, taken with food, usually in the morning. Start at the lower end, assess tolerance, and stay consistent; more is not automatically better.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
Adults looking to address premature ageing, low energy, cellular stress. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
As part of the Peptide category, Mod GRF 1-29 can be used on its own or layered into a broader protocol — see the Goes with panel for evidence-aligned pairings.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
Request received.
We'll route this to a clinician familiar with peptide protocols. Expect a reply within about 48 hours.
How's your experience? We read every note.